Five things that changed this week for clinics that prescribe, inject or compound. Every item links to the agency that issued it.
Rule Watch, September 25, 2026: FDA says a dropdown is not a clinical judgment Read More »
Alabama lets video carry a testosterone program. It does not let video start one. The first encounter has to be in person, and the clock resets every 12 months.
Alabama telehealth testosterone: the 12-month in-person rule Read More »
Louisiana lets video carry a testosterone program for twelve months at a time. It does not let video start one, and the 2026 weight-loss telehealth law did not change that.
Louisiana telehealth testosterone: one in-person visit a year, with the prescriber Read More »
Minnesota wrote two telehealth exceptions into its exam rule. Testosterone is in neither. The fix is structural: one in-person exam inside your group, then video.
Minnesota telehealth testosterone: the in-person exam comes first Read More »
Rhode Island’s binding rule never mentions an in-person exam. The Board’s own guideline says controlled substances need one. Build for the guideline.
Rhode Island telehealth testosterone: the rule is silent, the Board is not Read More »
The federal rule lets a video visit start testosterone through December 31, 2026. Eight states do not, and three more attach an in-person string. The table is the whole map.
Telehealth testosterone by state: where a video visit can start TRT Read More »
Most clinics find out about LegitScript the same way. The Google Ads account gets suspended, or Meta rejects a GLP-1 ad, or the payment processor sends an email asking for a certification number. Then someone types “legit scripts” into Google and finds a dozen companies offering to fast-track it. Here’s what they tend to leave
GLP-1 brands are the reason most people learn what LegitScript is. Weight loss is the biggest telehealth category, the most advertised, and the most scrutinised. LegitScript has publicly reported a surge in violative GLP-1 ads, and the platforms tightened with it. The good news: a GLP-1 program can be certified. The review just runs through
LegitScript for GLP-1 and weight loss brands: what reviewers check in 2026 Read More »
Short answer: a med spa that only treats patients in person usually doesn’t. A med spa that prescribes online, ships medication, or wants to advertise prescription drugs usually does. Most med spas in 2026 are drifting from the first group into the second without noticing, usually the day they add a weight loss program. The
Does a med spa need LegitScript certification? Read More »
Testosterone is where telehealth compliance gets harder, because it’s a Schedule III controlled substance. Everything that applies to a GLP-1 brand applies here, plus federal controlled substance law, DEA registration and a telemedicine rule that has been “temporary” since 2020. LegitScript certifies TRT and HRT programs. It reviews them with the controlled-substance questions front and
LegitScript for TRT and testosterone telehealth: the controlled substance problem Read More »
Peptides are the fastest-growing category in wellness medicine and the one with the least settled rules. That makes them the place LegitScript applications most often go wrong, usually because of a single product listing the owner didn’t think twice about. Three kinds of peptide product, three answers Product Can it sit in a certified business? […]
LegitScript and peptides: what reviewers ask about BPC-157, RUO and compounding Read More »
Two organizations do most of the healthcare merchant certification that ad platforms and card networks accept in the US: LegitScript and the National Association of Boards of Pharmacy (NABP). They overlap more than they used to, so the choice isn’t always obvious. Side by side LegitScript Healthcare Merchant Certification NABP Healthcare Merchant Accreditation NABP Digital
LegitScript vs NABP: which certification does your clinic or pharmacy need? Read More »
